Scientific paper - Review paper
The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
Pharmaceuticals, 17 (2024), 10; 1313. https://doi.org/10.3390/ph17101313


Cite this document

Harej Hrkać, A., Pilipović, K., Belančić, A., Juretić, L., Vitezić, D. & Mršić Pelčić, J. (2024). The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury. Pharmaceuticals, 17. (10). doi: 10.3390/ph17101313

Harej Hrkać, Anja, et al. "The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury." Pharmaceuticals, vol. 17, no. 10, 2024. https://doi.org/10.3390/ph17101313

Harej Hrkać, Anja, Kristina Pilipović, Andrej Belančić, Lea Juretić, Dinko Vitezić and Jasenka Mršić Pelčić. "The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury." Pharmaceuticals 17, no. 10 (2024). https://doi.org/10.3390/ph17101313

Harej Hrkać, A., et al. (2024) 'The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury', Pharmaceuticals, 17(10). doi: 10.3390/ph17101313

Harej Hrkać A, Pilipović K, Belančić A, Juretić L, Vitezić D, Mršić Pelčić J. The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury. Pharmaceuticals [Internet]. 2024 October 01 [cited 2024 December 02];17(10). doi: 10.3390/ph17101313

A. Harej Hrkać, K. Pilipović, A. Belančić, L. Juretić, D. Vitezić and J. Mršić Pelčić, "The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury", Pharmaceuticals, vol. 17, no. 10, October 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:467040. [Accessed: 02 December 2024]

Please login to the repository to save this object to your list.